Navigation Links
ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System
Date:2/9/2009

MINNEAPOLIS, Feb. 9 /PRNewswire/ -- ARKRAY USA, Inc., the 5th largest Blood Glucose Monitoring Company in the world, announced 510(k) clearance from the U.S. Food and Drug Administration for the GLUCOCARD(R) 01-mini Blood Glucose Monitoring System.

This new system requires no coding, displays results in 7 seconds, requires a tiny 0.3 micro liter sample size, and was developed to use the same affordable test strips as the downloadable GLUCOCARD(R) 01 system that launched in 2008. GLUCOCARD(R) 01-mini has AST and features pre/post meal flags. Most notable, the GLUCOCARD(R) 01-mini is the only system on the market that features interchangeable faceplates so users may personalize the look of their monitoring system. It also features an easy-to-read display. The GLUCOCARD(R) 01-mini is distinguished by its leading edge design and technology. Recent clinical data showed GLUCOCARD(R) 01-mini to be highly accurate, precise and easy-to-use.

"ARKRAY is excited to announce a new addition to our growing line of GLUCOCARD(R) blood glucose monitoring systems. The GLUCOCARD(R) 01-mini system follows the GLUCOCARD(R) brand image of sleek, compact, and discreet. The GLUCOCARD(R) 01-mini is unlike other glucose monitors in the market, it features interchangeable face plates," said Jonathan Chapman, President of ARKRAY USA, Inc. "An assortment of faceplates are available, we anticipate making exciting changes to this category by possibly adding a free face plate to each test strip carton and hope to soon make design software available on our website (http://www.glucocardusa.com) so that our customers can make their GLUCOCARD(R) 01-mini as unique as they are."

About ARKRAY USA

ARKRAY has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self- testing systems. ARKRAY's primary focus throughout that time has been diabetes, developing the world's first hand held blood glucose meter (late 1960s) and the world's first A1C analyzer (1982). ARKRAY is one of the few diabetes testing companies in the US market today that undertakes in-house each step of the development process to bring products to market. ARKRAY is among the leading medical device companies noted for their patent-based intellectual property by Patent Board (Wall Street Journal 11/14/08).


'/>"/>
SOURCE ARKRAY USA, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ARKRAY USA Nationally Launches GLUCOCARD(TM) X-METER Blood Glucose Monitoring System
2. San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program
3. Pulse Systems Receives Dual Certification Under ISO 13485:2003 and ISO 9001:2008
4. Envoii Healthcare License Holder Private Access Inc. Receives TEPR Award
5. Neovasc Receives CE Mark Approval for Peripatch(TM) Aegis Staple Line Reinforcement Product
6. HEALTHeCAREERS Network Receives WEDDLE's 2009 User's Choice Award
7. Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
8. THE RESULTS ARE IN! VASER(R) Lipo Receives 95% Approval Rating by Physician Users
9. University of Alberta organic chemist receives top young Canadian scientist prize
10. Walden Universitys M.S. in Mental Health Counseling Program Receives CACREP Accreditation
11. Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Brady (NYSE:BRC), a ... B-595 and B-7569 vinyl label materials received certification for the ... are tested to remain intact and legible, for use on chemical drums shipped by ...
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... ... April 21, 2017 , ... Westside Dental Associates ... dental care since 1985. After thirty-two years, Dr. Latner has become one of the ... my numerous clients over the years with all their dental needs,” said Dr. Latner, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology: